While they were not able to scientifically confirm the reasoning behind this, the authors hypothesized that CRMO patients with “low” expression IL-10 promoter haplotype blocks (ACC and ATA) may have developed and been diagnosed with different and more severe autoinflammatory conditions. Here, IL10 is linked to chronic recurrent multifocal osteomyelitis.